Literature DB >> 21807019

Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

S D Schlussman1, J Cassin, Y Zhang, O Levran, A Ho, M J Kreek.   

Abstract

We have previously shown strain and dose differences in heroin-induced behavior, reward and regional expression of somatostatin receptor mRNAs in C57BL/6J and 129P3/J mice. Using Real Time PCR we examined the effects of five doses of heroin on the levels of the transcripts of endogenous opioid peptides and their receptors and dopaminergic receptors in the mesocorticolimbic and nigrostriatal pathways in these same mice. Compared to C57BL/6J animals, 129P3/J mice had higher mRNA levels of Oprk1 in the nucleus accumbens and of Oprd1 in the nucleus accumbens and a region containing both the substantia nigra and ventral tegmental area (SN/VTA). In the cortex of 129P3/J mice, lower levels of both Oprk1 and Oprd1 mRNAs were observed. Pdyn mRNA was also lower in the caudate putamen of 129P3/J mice. Strain differences were not found in the levels of Oprm1, Penk or Pomc mRNAs in any region examined. Within strains, complex patterns of heroin dose-dependent changes in the levels of Oprm1, Oprk1 and Oprd1 mRNAs were observed in the SN/VTA. Additionally, Oprd1 mRNA was dose-dependently elevated in the hypothalamus. Also in the hypothalamus, we found higher levels of Drd1a mRNA in C57BL/6J mice than in 129P3/J animals and higher levels of DAT (Slc6a3) mRNA in the caudate putamen of C57BL/6J animals than in 129P3/J counterparts. Heroin had dose-related effects on Drd1a mRNA in the hypothalamus and on Drd2 mRNA in the caudate putamen.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807019      PMCID: PMC3201798          DOI: 10.1016/j.pbb.2011.07.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  85 in total

1.  The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.

Authors:  J P De Waele; D N Papachristou; C Gianoulakis
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

2.  Strain-specific effects of ethanol on open field activity in inbred mice.

Authors:  J C Crabbe; J S Janowsky; E R Young; H Rigter
Journal:  Subst Alcohol Actions Misuse       Date:  1980

3.  Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Synapse       Date:  2003-12-01       Impact factor: 2.562

4.  Effects of heroin, alone or in combination with other drugs, on the locomotor activity in two inbred strains of mice.

Authors:  C Castellano; L Filibeck; A Oliverio
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

5.  Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens.

Authors:  Q Z Zhai; S Persson; C Post; F Nyberg
Journal:  Neuropharmacology       Date:  1993-07       Impact factor: 5.250

6.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

7.  Opiates and the gastrointestinal tract.

Authors:  S J Konturek
Journal:  Am J Gastroenterol       Date:  1980-09       Impact factor: 10.864

8.  Strain differences in maintenance of cocaine self-administration and their relationship to novelty activity responses.

Authors:  Therese A Kosten; Xiang Yang Zhang; Colin N Haile
Journal:  Behav Neurosci       Date:  2007-04       Impact factor: 1.912

9.  Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine.

Authors:  K P Gudehithlu; H N Bhargava
Journal:  Peptides       Date:  1995       Impact factor: 3.750

10.  Effects of "binge" pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice.

Authors:  S D Schlussman; A Ho; Y Zhou; A E Curtis; M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  1998-06       Impact factor: 3.533

View more
  6 in total

Review 1.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 2.  κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Authors:  Eduardo R Butelman; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

3.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

4.  Proopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice.

Authors:  K Niikura; Y Zhou; A Ho; M J Kreek
Journal:  Neuroscience       Date:  2013-01-18       Impact factor: 3.590

5.  Regional mRNA expression of GABAergic receptor subunits in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  S D Schlussman; M Buonora; A J Brownstein; Y Zhang; A Ho; M J Kreek
Journal:  Brain Res       Date:  2013-05-31       Impact factor: 3.252

6.  Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.

Authors:  Igor Bazov; Daniil Sarkisyan; Olga Kononenko; Hiroyuki Watanabe; Tatiana Yakovleva; Anita C Hansson; Wolfgang H Sommer; Rainer Spanagel; Georgy Bakalkin
Journal:  Mol Neurobiol       Date:  2018-01-30       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.